L F Camargo1, A B A Esteves1, L R S Ulisses1, G G Rivelli1, M Mazzali2. 1. Division of Nephrology, Department of Medicine, School of Medical Sciences, State University of Campinas-UNICAMP, Campinas, São Paulo, Brazil. 2. Division of Nephrology, Department of Medicine, School of Medical Sciences, State University of Campinas-UNICAMP, Campinas, São Paulo, Brazil. Electronic address: marildamazzali@gmail.com.
Abstract
INTRODUCTION: Urinary tract infection (UTI) is the most common infection posttransplant. However, the risk factors for and the impact of UTIs remain controversial. The aim of this study was to identify the incidence of posttransplant UTIs in a series of renal transplant recipients from deceased donors. Secondary objectives were to identify: (1) the most frequent infectious agents; (2) risk factors related to donor; (3) risk factors related to recipients; and (4) impact of UTI on graft function. PATIENTS AND METHODS: This was a retrospective analysis of medical records from renal transplant patients from January to December 2010. Local ethics committee approved the protocol. RESULTS: The incidence of UTI in this series was 34.2%. Risk factors for UTI were older age, (independent of gender), biopsy-proven acute rejection episodes, and kidneys from deceased donors (United Network for Organ Sharing criteria). For female patients, the number of pretransplant pregnancies was an additional risk factor. Recurrent UTI was observed in 44% of patients from the UTI group. The most common infectious agents were Escherichia coli and Klebsiella pneumoniae, for both isolated and recurrent UTI. No difference in renal graft function or immunosuppressive therapy was observed between groups after the 1-year follow-up. CONCLUSIONS: In this series, older age, previous pregnancy, kidneys from expanded criteria donors, and biopsy-proven acute rejection episodes were risk factors for posttransplant UTI. Recurrence of UTI was observed in 44%, with no negative impact on graft function or survival.
INTRODUCTION:Urinary tract infection (UTI) is the most common infection posttransplant. However, the risk factors for and the impact of UTIs remain controversial. The aim of this study was to identify the incidence of posttransplant UTIs in a series of renal transplant recipients from deceased donors. Secondary objectives were to identify: (1) the most frequent infectious agents; (2) risk factors related to donor; (3) risk factors related to recipients; and (4) impact of UTI on graft function. PATIENTS AND METHODS: This was a retrospective analysis of medical records from renal transplant patients from January to December 2010. Local ethics committee approved the protocol. RESULTS: The incidence of UTI in this series was 34.2%. Risk factors for UTI were older age, (independent of gender), biopsy-proven acute rejection episodes, and kidneys from deceased donors (United Network for Organ Sharing criteria). For female patients, the number of pretransplant pregnancies was an additional risk factor. Recurrent UTI was observed in 44% of patients from the UTI group. The most common infectious agents were Escherichia coli and Klebsiella pneumoniae, for both isolated and recurrent UTI. No difference in renal graft function or immunosuppressive therapy was observed between groups after the 1-year follow-up. CONCLUSIONS: In this series, older age, previous pregnancy, kidneys from expanded criteria donors, and biopsy-proven acute rejection episodes were risk factors for posttransplant UTI. Recurrence of UTI was observed in 44%, with no negative impact on graft function or survival.
Authors: Marion Hemmersbach-Miller; Barbara D Alexander; Debra L Sudan; Carl Pieper; Kenneth E Schmader Journal: Eur J Clin Microbiol Infect Dis Date: 2018-10-23 Impact factor: 3.267
Authors: Justin R Gregg; Caroline L Kang; Thomas R Talbot; Derek Moore; S Duke Herrell; Roger Dmochowski; Daniel A Barocas Journal: Urol Pract Date: 2016-10-22
Authors: Adnan S Gondos; Khaled A Al-Moyed; Abdul Baki A Al-Robasi; Hassan A Al-Shamahy; Naelah A Alyousefi Journal: PLoS One Date: 2015-12-10 Impact factor: 3.240
Authors: Jakob E Brune; Michael Dickenmann; Caroline Wehmeier; Daniel Sidler; Laura Walti; Dela Golshayan; Oriol Manuel; Karine Hadaya; Dionysios Neofytos; Aurelia Schnyder; Katia Boggian; Thomas Müller; Thomas Schachtner; Nina Khanna; Stefan Schaub Journal: Am J Transplant Date: 2022-03-26 Impact factor: 9.369